Warm antibody autoimmune hemolytic anemia in pregnancy: A case report

Autor: Zorana Budakov-Obradovic, Jasmina Grujic, Nevenka Bujandric

Publikováno v: Medical review. 73:235-238

Introduction. Warm autoimmune hemolytic anemia is the presence of warm autoantibodies against red blood cell with or without complement activation. The presence of warm autoantibodies on the red blood cells is detected by direct antiglobulin test wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d144229a0b64ab179a937f4334d6e1c
https://doi.org/10.2298/mpns2008235b

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

Autor: Eszter Nagy, Graham P. Collins, Fiona Miall, K Paterson, Paul Fields, John Radford, Tobias Menne, Sarah Pirrie, Keith Wheatley, Victoria Warbey, Rachel Reed, Kim Linton, Pamela McKay, Adam Gibb, Ivona Baricevic-Jones, Andrew Davies, Sally F. Barrington

Publikováno v: Radford, J 2020, ' Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY) ', British Jounal Haematology . https://doi.org/10.1111/bjh.17073

Content: Warm antibody autoimmune hemolytic anemia (wAIHA) is a rare disorder that can have serious complications. In this disorder, autoantibodies bind to antigens on red blood cells leading to phagocytosis and destruction of the cells. This is medi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765e2143350ae540624136426f1106dd
https://doi.org/10.1111/bjh.17073

Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review

Autor: Reinhold Munker, Peter B. Doley, Georges Tanios

Publikováno v: European Journal of Haematology. 102:157-162

Background Immune checkpoint inhibitors (CPI) are widely used in modern oncology and have improved the prognosis of lung cancer, malignant melanoma, and other malignancies. Unlike cytotoxic chemotherapy, drugs such as nivolumab, pembrolizumab, and ip

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16725b7d21a21bd4d440045523fb7ca5
https://doi.org/10.1111/ejh.13187

Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab

Autor: Andrew Hwang, Constantin A Dasanu, Andrew S Iskandar

Publikováno v: Journal of Oncology Pharmacy Practice. 25:2016-2018

Castleman disease is a rare B-cell lymphoproliferative disorder characterized by lymph node enlargement with or without constitutional signs. Herein, we describe a unique patient with multicentric Castleman disease and retroviral infection who presen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db81c2b0913b004dc2dcd374ddd94bf
https://doi.org/10.1177/1078155218816775

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Autor: Alain Kentos, André Delannoy, Daan Dierickx

Publikováno v: Blood. 125:3223-3229

Warm antibody hemolytic anemia is the most common form of autoimmune hemolytic anemia. When therapy is needed, corticosteroids remain the cornerstone of initial treatment but are able to cure only a minority of patients (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41de2d7760b4b37fb5115234000b5e67
https://doi.org/10.1182/blood-2015-01-588392